Embla Medical hf.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OSSUY research report →
Companywww.emblamedical.com
Embla Medical hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. It operates through the following geographical segments: Americas; Europe Middle-East and Africa; and Americas and Aisa-Pacific. The company was founded by Össur Kristinsson in 1971 and is headquartered in Reykjavík, Iceland.
- CEO
- Sveinn Solvason
- IPO
- 2018
- Employees
- 4,000
- HQ
- Reykjavik, IS
Price Chart
Valuation
- Market Cap
- $1.63B
- P/E
- 18.93
- P/S
- 1.70
- P/B
- 1.80
- EV/EBITDA
- 11.08
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 58.89%
- Op Margin
- 13.16%
- Net Margin
- 8.93%
- ROE
- 9.82%
- ROIC
- 6.41%
Growth & Income
- Revenue
- $932.24M · 9.05%
- Net Income
- $83.65M · 22.52%
- EPS
- $0.20 · 25.00%
- Op Income
- $125.17M
- FCF YoY
- 29.20%
Performance & Tape
- 52W High
- $5.61
- 52W Low
- $3.67
- 50D MA
- $3.80
- 200D MA
- $4.49
- Beta
- 0.45
- Avg Volume
- 8
Get TickerSpark's AI analysis on OSSUY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our OSSUY Coverage
We haven't published any research on OSSUY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OSSUY Report →